Review



il 10 galectin 9  (Galectin Therapeutics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Galectin Therapeutics il 10 galectin 9
    Accuracy of CSF diagnostic markers for PCNSL. Boxplots depicted the distribution of <t>CSF</t> <t>IL-10</t> ( A ), CXCL13 ( B ), IL-2RA ( C ), FasL ( D ), TIM-3 ( E ), <t>and</t> <t>galectin-9</t> ( F ) levels in PCNSL, neuroimmunological diseases, other brain tumors, and iNPH patients. Median values were represented by the horizontal bar, IQR by boxes, 1.5 × IQR by whiskers, and individual values by dots. IL-10 and IL-2RA are shown on a logarithmic scale due to the highly skewed distribution with a large proportion of zero or low values and a small number of extremely high values. The y -axis is displayed on a logarithmic scale after log10 transformation of IL-10 and IL-2RA concentrations with the addition of a constant of 1, while tick labels indicate the original values in pg/mL. **, adjusted p < 0.01. ***, adjusted p < 0.001. n.s., not significant. Holm-adjusted Dunn’s tests were used to compare PCNSL with the other groups. G–I ROC curves showed the diagnostic performance of CSF IL-10, CXCL13, IL-2RA, FasL, TIM-3, and galectin-9 for distinguishing PCNSL from different disease groups. The corresponding AUC values were shown. G PCNSL versus all other diseases. H PCNSL versus neuroimmunological diseases. (I) PCNSL versus other brain tumors. AUC values were shown in the legends of each panel AUC, area under the curve; CSF, cerebrospinal fluid; CXCL13, C–X–C motif chemokine ligand 13; FasL, Fas ligand; IL-2RA, interleukin-2 receptor chain alpha; IL-10, interleukin-10; iNPH, idiopathic normal pressure hydrocephalus; IQR, interquartile range; PCNSL, primary central nervous system lymphoma; ROC, Receiver operating characteristic; TIM-3, T-cell immunoglobulin and mucin domain 3
    Il 10 Galectin 9, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+10+galectin+9/pmc13046686-15-0-2?v=Galectin+Therapeutics
    Average 86 stars, based on 1 article reviews
    il 10 galectin 9 - by Bioz Stars, 2026-07
    86/100 stars

    Images

    1) Product Images from "Soluble TIM-3 and galectin-9 serve as additional diagnostic biomarkers in primary central nervous system lymphoma"

    Article Title: Soluble TIM-3 and galectin-9 serve as additional diagnostic biomarkers in primary central nervous system lymphoma

    Journal: Journal of Neurology

    doi: 10.1007/s00415-026-13791-4

    Accuracy of CSF diagnostic markers for PCNSL. Boxplots depicted the distribution of CSF IL-10 ( A ), CXCL13 ( B ), IL-2RA ( C ), FasL ( D ), TIM-3 ( E ), and galectin-9 ( F ) levels in PCNSL, neuroimmunological diseases, other brain tumors, and iNPH patients. Median values were represented by the horizontal bar, IQR by boxes, 1.5 × IQR by whiskers, and individual values by dots. IL-10 and IL-2RA are shown on a logarithmic scale due to the highly skewed distribution with a large proportion of zero or low values and a small number of extremely high values. The y -axis is displayed on a logarithmic scale after log10 transformation of IL-10 and IL-2RA concentrations with the addition of a constant of 1, while tick labels indicate the original values in pg/mL. **, adjusted p < 0.01. ***, adjusted p < 0.001. n.s., not significant. Holm-adjusted Dunn’s tests were used to compare PCNSL with the other groups. G–I ROC curves showed the diagnostic performance of CSF IL-10, CXCL13, IL-2RA, FasL, TIM-3, and galectin-9 for distinguishing PCNSL from different disease groups. The corresponding AUC values were shown. G PCNSL versus all other diseases. H PCNSL versus neuroimmunological diseases. (I) PCNSL versus other brain tumors. AUC values were shown in the legends of each panel AUC, area under the curve; CSF, cerebrospinal fluid; CXCL13, C–X–C motif chemokine ligand 13; FasL, Fas ligand; IL-2RA, interleukin-2 receptor chain alpha; IL-10, interleukin-10; iNPH, idiopathic normal pressure hydrocephalus; IQR, interquartile range; PCNSL, primary central nervous system lymphoma; ROC, Receiver operating characteristic; TIM-3, T-cell immunoglobulin and mucin domain 3
    Figure Legend Snippet: Accuracy of CSF diagnostic markers for PCNSL. Boxplots depicted the distribution of CSF IL-10 ( A ), CXCL13 ( B ), IL-2RA ( C ), FasL ( D ), TIM-3 ( E ), and galectin-9 ( F ) levels in PCNSL, neuroimmunological diseases, other brain tumors, and iNPH patients. Median values were represented by the horizontal bar, IQR by boxes, 1.5 × IQR by whiskers, and individual values by dots. IL-10 and IL-2RA are shown on a logarithmic scale due to the highly skewed distribution with a large proportion of zero or low values and a small number of extremely high values. The y -axis is displayed on a logarithmic scale after log10 transformation of IL-10 and IL-2RA concentrations with the addition of a constant of 1, while tick labels indicate the original values in pg/mL. **, adjusted p < 0.01. ***, adjusted p < 0.001. n.s., not significant. Holm-adjusted Dunn’s tests were used to compare PCNSL with the other groups. G–I ROC curves showed the diagnostic performance of CSF IL-10, CXCL13, IL-2RA, FasL, TIM-3, and galectin-9 for distinguishing PCNSL from different disease groups. The corresponding AUC values were shown. G PCNSL versus all other diseases. H PCNSL versus neuroimmunological diseases. (I) PCNSL versus other brain tumors. AUC values were shown in the legends of each panel AUC, area under the curve; CSF, cerebrospinal fluid; CXCL13, C–X–C motif chemokine ligand 13; FasL, Fas ligand; IL-2RA, interleukin-2 receptor chain alpha; IL-10, interleukin-10; iNPH, idiopathic normal pressure hydrocephalus; IQR, interquartile range; PCNSL, primary central nervous system lymphoma; ROC, Receiver operating characteristic; TIM-3, T-cell immunoglobulin and mucin domain 3

    Techniques Used: Diagnostic Assay, Transformation Assay

    Correlations and clustering of diagnostic markers in PCNSL. Scatter plots and correlation analyses showed correlations between IL-10 and CXCL13 ( A ), IL-10 and IL-2RA ( B ), IL-10 and FasL ( C ), IL-10 and TIM-3 ( D ), IL-10 and galectin-9 ( E ), CXCL13 and IL-2RA ( F ), CXCL13 and FasL ( G ), CXCL13 and TIM-3 ( H ), CXCL13 and galectin-9 ( I ), IL-2RA and FasL ( J ), IL-2RA and TIM-3 ( K ), IL-2RA and galectin-9 (L), FasL and TIM-3 ( M ), FasL and galectin-9 ( N ), and TIM-3 and galectin-9 ( O ). Spearman’s rank correlation was used to measure the degree of correlation between CSF diagnostic markers. P Correlation matrix showed Spearman’s rank correlation coefficients between CSF diagnostic markers in PCNSL patients. Q Hierarchical clustering of CSF diagnostic markers in PCNSL patients based on Spearman’s rank correlation coefficients. Clustering was performed using 1 − Spearman’s correlation coefficient as the distance metric with the complete linkage method. CSF, cerebrospinal fluid; CXCL13, C–X–C motif chemokine ligand 13; FasL, Fas ligand; IL-2RA, interleukin-2 receptor chain alpha; IL-10, interleukin-10; PCNSL, primary central nervous system lymphoma; TIM-3, T-cell immunoglobulin and mucin domain 3
    Figure Legend Snippet: Correlations and clustering of diagnostic markers in PCNSL. Scatter plots and correlation analyses showed correlations between IL-10 and CXCL13 ( A ), IL-10 and IL-2RA ( B ), IL-10 and FasL ( C ), IL-10 and TIM-3 ( D ), IL-10 and galectin-9 ( E ), CXCL13 and IL-2RA ( F ), CXCL13 and FasL ( G ), CXCL13 and TIM-3 ( H ), CXCL13 and galectin-9 ( I ), IL-2RA and FasL ( J ), IL-2RA and TIM-3 ( K ), IL-2RA and galectin-9 (L), FasL and TIM-3 ( M ), FasL and galectin-9 ( N ), and TIM-3 and galectin-9 ( O ). Spearman’s rank correlation was used to measure the degree of correlation between CSF diagnostic markers. P Correlation matrix showed Spearman’s rank correlation coefficients between CSF diagnostic markers in PCNSL patients. Q Hierarchical clustering of CSF diagnostic markers in PCNSL patients based on Spearman’s rank correlation coefficients. Clustering was performed using 1 − Spearman’s correlation coefficient as the distance metric with the complete linkage method. CSF, cerebrospinal fluid; CXCL13, C–X–C motif chemokine ligand 13; FasL, Fas ligand; IL-2RA, interleukin-2 receptor chain alpha; IL-10, interleukin-10; PCNSL, primary central nervous system lymphoma; TIM-3, T-cell immunoglobulin and mucin domain 3

    Techniques Used: Diagnostic Assay

    Comparison of PFS in PCNSL according to diagnostic marker levels. Kaplan–Meier curves for PFS in PCNSL patients were compared according to CSF IL-10 ( A ), CXCL13 ( B ), IL-2RA ( C ), FasL ( D ), TIM-3 ( E ), and galectin-9 ( F ) levels. PFS was compared using the log-rank test. CSF, cerebrospinal fluid; CXCL13, C–X–C motif chemokine ligand 13; FasL, Fas ligand; IL-2RA, interleukin-2 receptor chain alpha; IL-10, interleukin-10; PCNSL, primary central nervous system lymphoma; PFS, progression-free survival; TIM-3, T-cell immunoglobulin and mucin domain 3
    Figure Legend Snippet: Comparison of PFS in PCNSL according to diagnostic marker levels. Kaplan–Meier curves for PFS in PCNSL patients were compared according to CSF IL-10 ( A ), CXCL13 ( B ), IL-2RA ( C ), FasL ( D ), TIM-3 ( E ), and galectin-9 ( F ) levels. PFS was compared using the log-rank test. CSF, cerebrospinal fluid; CXCL13, C–X–C motif chemokine ligand 13; FasL, Fas ligand; IL-2RA, interleukin-2 receptor chain alpha; IL-10, interleukin-10; PCNSL, primary central nervous system lymphoma; PFS, progression-free survival; TIM-3, T-cell immunoglobulin and mucin domain 3

    Techniques Used: Comparison, Diagnostic Assay, Marker



    Similar Products

    il 10 galectin 9  (Galectin Therapeutics)
    86
    Galectin Therapeutics il 10 galectin 9
    Accuracy of CSF diagnostic markers for PCNSL. Boxplots depicted the distribution of <t>CSF</t> <t>IL-10</t> ( A ), CXCL13 ( B ), IL-2RA ( C ), FasL ( D ), TIM-3 ( E ), <t>and</t> <t>galectin-9</t> ( F ) levels in PCNSL, neuroimmunological diseases, other brain tumors, and iNPH patients. Median values were represented by the horizontal bar, IQR by boxes, 1.5 × IQR by whiskers, and individual values by dots. IL-10 and IL-2RA are shown on a logarithmic scale due to the highly skewed distribution with a large proportion of zero or low values and a small number of extremely high values. The y -axis is displayed on a logarithmic scale after log10 transformation of IL-10 and IL-2RA concentrations with the addition of a constant of 1, while tick labels indicate the original values in pg/mL. **, adjusted p < 0.01. ***, adjusted p < 0.001. n.s., not significant. Holm-adjusted Dunn’s tests were used to compare PCNSL with the other groups. G–I ROC curves showed the diagnostic performance of CSF IL-10, CXCL13, IL-2RA, FasL, TIM-3, and galectin-9 for distinguishing PCNSL from different disease groups. The corresponding AUC values were shown. G PCNSL versus all other diseases. H PCNSL versus neuroimmunological diseases. (I) PCNSL versus other brain tumors. AUC values were shown in the legends of each panel AUC, area under the curve; CSF, cerebrospinal fluid; CXCL13, C–X–C motif chemokine ligand 13; FasL, Fas ligand; IL-2RA, interleukin-2 receptor chain alpha; IL-10, interleukin-10; iNPH, idiopathic normal pressure hydrocephalus; IQR, interquartile range; PCNSL, primary central nervous system lymphoma; ROC, Receiver operating characteristic; TIM-3, T-cell immunoglobulin and mucin domain 3
    Il 10 Galectin 9, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+10+galectin+9/pmc13046686-15-0-2?v=Galectin+Therapeutics
    Average 86 stars, based on 1 article reviews
    il 10 galectin 9 - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Accuracy of CSF diagnostic markers for PCNSL. Boxplots depicted the distribution of CSF IL-10 ( A ), CXCL13 ( B ), IL-2RA ( C ), FasL ( D ), TIM-3 ( E ), and galectin-9 ( F ) levels in PCNSL, neuroimmunological diseases, other brain tumors, and iNPH patients. Median values were represented by the horizontal bar, IQR by boxes, 1.5 × IQR by whiskers, and individual values by dots. IL-10 and IL-2RA are shown on a logarithmic scale due to the highly skewed distribution with a large proportion of zero or low values and a small number of extremely high values. The y -axis is displayed on a logarithmic scale after log10 transformation of IL-10 and IL-2RA concentrations with the addition of a constant of 1, while tick labels indicate the original values in pg/mL. **, adjusted p < 0.01. ***, adjusted p < 0.001. n.s., not significant. Holm-adjusted Dunn’s tests were used to compare PCNSL with the other groups. G–I ROC curves showed the diagnostic performance of CSF IL-10, CXCL13, IL-2RA, FasL, TIM-3, and galectin-9 for distinguishing PCNSL from different disease groups. The corresponding AUC values were shown. G PCNSL versus all other diseases. H PCNSL versus neuroimmunological diseases. (I) PCNSL versus other brain tumors. AUC values were shown in the legends of each panel AUC, area under the curve; CSF, cerebrospinal fluid; CXCL13, C–X–C motif chemokine ligand 13; FasL, Fas ligand; IL-2RA, interleukin-2 receptor chain alpha; IL-10, interleukin-10; iNPH, idiopathic normal pressure hydrocephalus; IQR, interquartile range; PCNSL, primary central nervous system lymphoma; ROC, Receiver operating characteristic; TIM-3, T-cell immunoglobulin and mucin domain 3

    Journal: Journal of Neurology

    Article Title: Soluble TIM-3 and galectin-9 serve as additional diagnostic biomarkers in primary central nervous system lymphoma

    doi: 10.1007/s00415-026-13791-4

    Figure Lengend Snippet: Accuracy of CSF diagnostic markers for PCNSL. Boxplots depicted the distribution of CSF IL-10 ( A ), CXCL13 ( B ), IL-2RA ( C ), FasL ( D ), TIM-3 ( E ), and galectin-9 ( F ) levels in PCNSL, neuroimmunological diseases, other brain tumors, and iNPH patients. Median values were represented by the horizontal bar, IQR by boxes, 1.5 × IQR by whiskers, and individual values by dots. IL-10 and IL-2RA are shown on a logarithmic scale due to the highly skewed distribution with a large proportion of zero or low values and a small number of extremely high values. The y -axis is displayed on a logarithmic scale after log10 transformation of IL-10 and IL-2RA concentrations with the addition of a constant of 1, while tick labels indicate the original values in pg/mL. **, adjusted p < 0.01. ***, adjusted p < 0.001. n.s., not significant. Holm-adjusted Dunn’s tests were used to compare PCNSL with the other groups. G–I ROC curves showed the diagnostic performance of CSF IL-10, CXCL13, IL-2RA, FasL, TIM-3, and galectin-9 for distinguishing PCNSL from different disease groups. The corresponding AUC values were shown. G PCNSL versus all other diseases. H PCNSL versus neuroimmunological diseases. (I) PCNSL versus other brain tumors. AUC values were shown in the legends of each panel AUC, area under the curve; CSF, cerebrospinal fluid; CXCL13, C–X–C motif chemokine ligand 13; FasL, Fas ligand; IL-2RA, interleukin-2 receptor chain alpha; IL-10, interleukin-10; iNPH, idiopathic normal pressure hydrocephalus; IQR, interquartile range; PCNSL, primary central nervous system lymphoma; ROC, Receiver operating characteristic; TIM-3, T-cell immunoglobulin and mucin domain 3

    Article Snippet: IL-10 + Galectin-9 , 26.2 , 34.6 , 0.991 , 0.141 , 0.904 , .

    Techniques: Diagnostic Assay, Transformation Assay

    Correlations and clustering of diagnostic markers in PCNSL. Scatter plots and correlation analyses showed correlations between IL-10 and CXCL13 ( A ), IL-10 and IL-2RA ( B ), IL-10 and FasL ( C ), IL-10 and TIM-3 ( D ), IL-10 and galectin-9 ( E ), CXCL13 and IL-2RA ( F ), CXCL13 and FasL ( G ), CXCL13 and TIM-3 ( H ), CXCL13 and galectin-9 ( I ), IL-2RA and FasL ( J ), IL-2RA and TIM-3 ( K ), IL-2RA and galectin-9 (L), FasL and TIM-3 ( M ), FasL and galectin-9 ( N ), and TIM-3 and galectin-9 ( O ). Spearman’s rank correlation was used to measure the degree of correlation between CSF diagnostic markers. P Correlation matrix showed Spearman’s rank correlation coefficients between CSF diagnostic markers in PCNSL patients. Q Hierarchical clustering of CSF diagnostic markers in PCNSL patients based on Spearman’s rank correlation coefficients. Clustering was performed using 1 − Spearman’s correlation coefficient as the distance metric with the complete linkage method. CSF, cerebrospinal fluid; CXCL13, C–X–C motif chemokine ligand 13; FasL, Fas ligand; IL-2RA, interleukin-2 receptor chain alpha; IL-10, interleukin-10; PCNSL, primary central nervous system lymphoma; TIM-3, T-cell immunoglobulin and mucin domain 3

    Journal: Journal of Neurology

    Article Title: Soluble TIM-3 and galectin-9 serve as additional diagnostic biomarkers in primary central nervous system lymphoma

    doi: 10.1007/s00415-026-13791-4

    Figure Lengend Snippet: Correlations and clustering of diagnostic markers in PCNSL. Scatter plots and correlation analyses showed correlations between IL-10 and CXCL13 ( A ), IL-10 and IL-2RA ( B ), IL-10 and FasL ( C ), IL-10 and TIM-3 ( D ), IL-10 and galectin-9 ( E ), CXCL13 and IL-2RA ( F ), CXCL13 and FasL ( G ), CXCL13 and TIM-3 ( H ), CXCL13 and galectin-9 ( I ), IL-2RA and FasL ( J ), IL-2RA and TIM-3 ( K ), IL-2RA and galectin-9 (L), FasL and TIM-3 ( M ), FasL and galectin-9 ( N ), and TIM-3 and galectin-9 ( O ). Spearman’s rank correlation was used to measure the degree of correlation between CSF diagnostic markers. P Correlation matrix showed Spearman’s rank correlation coefficients between CSF diagnostic markers in PCNSL patients. Q Hierarchical clustering of CSF diagnostic markers in PCNSL patients based on Spearman’s rank correlation coefficients. Clustering was performed using 1 − Spearman’s correlation coefficient as the distance metric with the complete linkage method. CSF, cerebrospinal fluid; CXCL13, C–X–C motif chemokine ligand 13; FasL, Fas ligand; IL-2RA, interleukin-2 receptor chain alpha; IL-10, interleukin-10; PCNSL, primary central nervous system lymphoma; TIM-3, T-cell immunoglobulin and mucin domain 3

    Article Snippet: IL-10 + Galectin-9 , 26.2 , 34.6 , 0.991 , 0.141 , 0.904 , .

    Techniques: Diagnostic Assay

    Comparison of PFS in PCNSL according to diagnostic marker levels. Kaplan–Meier curves for PFS in PCNSL patients were compared according to CSF IL-10 ( A ), CXCL13 ( B ), IL-2RA ( C ), FasL ( D ), TIM-3 ( E ), and galectin-9 ( F ) levels. PFS was compared using the log-rank test. CSF, cerebrospinal fluid; CXCL13, C–X–C motif chemokine ligand 13; FasL, Fas ligand; IL-2RA, interleukin-2 receptor chain alpha; IL-10, interleukin-10; PCNSL, primary central nervous system lymphoma; PFS, progression-free survival; TIM-3, T-cell immunoglobulin and mucin domain 3

    Journal: Journal of Neurology

    Article Title: Soluble TIM-3 and galectin-9 serve as additional diagnostic biomarkers in primary central nervous system lymphoma

    doi: 10.1007/s00415-026-13791-4

    Figure Lengend Snippet: Comparison of PFS in PCNSL according to diagnostic marker levels. Kaplan–Meier curves for PFS in PCNSL patients were compared according to CSF IL-10 ( A ), CXCL13 ( B ), IL-2RA ( C ), FasL ( D ), TIM-3 ( E ), and galectin-9 ( F ) levels. PFS was compared using the log-rank test. CSF, cerebrospinal fluid; CXCL13, C–X–C motif chemokine ligand 13; FasL, Fas ligand; IL-2RA, interleukin-2 receptor chain alpha; IL-10, interleukin-10; PCNSL, primary central nervous system lymphoma; PFS, progression-free survival; TIM-3, T-cell immunoglobulin and mucin domain 3

    Article Snippet: IL-10 + Galectin-9 , 26.2 , 34.6 , 0.991 , 0.141 , 0.904 , .

    Techniques: Comparison, Diagnostic Assay, Marker